Detalles de la búsqueda
1.
An interdisciplinary consensus on the management of brain metastases in patients with renal cell carcinoma.
CA Cancer J Clin
; 72(5): 454-489, 2022 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-35708940
2.
One Size Fits Some: Approaching Rare Malignancies of the Urinary Tract.
Curr Treat Options Oncol
; 25(2): 206-219, 2024 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-38315403
3.
Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study.
Lancet Oncol
; 24(3): 228-238, 2023 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-36858721
4.
Grade 3/4 Adverse Event Costs of Immuno-oncology Combination Therapies for Previously Untreated Advanced Renal Cell Carcinoma.
Oncologist
; 28(1): 72-79, 2023 01 18.
Artículo
en Inglés
| MEDLINE | ID: mdl-36124890
5.
Phase II trial of CV301 vaccine combined with atezolizumab in advanced urothelial carcinoma.
Cancer Immunol Immunother
; 72(3): 775-782, 2023 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35998004
6.
Cabozantinib in combination with atezolizumab in patients with metastatic castration-resistant prostate cancer: results from an expansion cohort of a multicentre, open-label, phase 1b trial (COSMIC-021).
Lancet Oncol
; 23(7): 899-909, 2022 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-35690072
7.
Longitudinal Evaluation of Circulating Tumor DNA Using Sensitive Amplicon-Based Next-Generation Sequencing to Identify Resistance Mechanisms to Immune Checkpoint Inhibitors for Advanced Urothelial Carcinoma.
Oncologist
; 27(5): e406-e409, 2022 05 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-35294031
8.
Associations between immune-related thyroid dysfunction and efficacy of immune checkpoint inhibitors: a systematic review and meta-analysis.
Cancer Immunol Immunother
; 71(8): 1795-1812, 2022 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-35022907
9.
A phase III, randomized, open-label study (CONTACT-02) of cabozantinib plus atezolizumab versus second novel hormone therapy in patients with metastatic castration-resistant prostate cancer.
Future Oncol
; 18(10): 1185-1198, 2022 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-35034502
10.
Enfortumab vedotin after PD-1 or PD-L1 inhibitors in cisplatin-ineligible patients with advanced urothelial carcinoma (EV201): a multicentre, single-arm, phase 2 trial.
Lancet Oncol
; 22(6): 872-882, 2021 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-33991512
11.
Results of a multicenter, phase 2 study of nivolumab and ipilimumab for patients with advanced rare genitourinary malignancies.
Cancer
; 127(6): 840-849, 2021 03 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-33216356
12.
Failure of Androgen-Deprivation Therapy Due to Ectopic hCG Secretion.
N Engl J Med
; 388(7): 660-662, 2023 02 16.
Artículo
en Inglés
| MEDLINE | ID: mdl-36791169
13.
Optimal pathological response after neoadjuvant chemotherapy for muscle-invasive bladder cancer: results from a global, multicentre collaboration.
BJU Int
; 128(5): 607-614, 2021 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-33909949
14.
A model combining clinical and genomic factors to predict response to PD-1/PD-L1 blockade in advanced urothelial carcinoma.
Br J Cancer
; 122(4): 555-563, 2020 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-31857723
15.
Real-World Assessment of Clinical Outcomes Among First-Line Sunitinib Patients with Clear Cell Metastatic Renal Cell Carcinoma (mRCC) by the International mRCC Database Consortium Risk Group.
Oncologist
; 25(5): 422-430, 2020 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-31971318
16.
Safety and efficacy of CDX-014, an antibody-drug conjugate directed against T cell immunoglobulin mucin-1 in advanced renal cell carcinoma.
Invest New Drugs
; 38(6): 1807-1814, 2020 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-32472319
17.
Differences in survival and impact of adjuvant chemotherapy in patients with variant histology of tumors of the renal pelvis.
World J Urol
; 38(9): 2227-2236, 2020 Sep.
Artículo
en Inglés
| MEDLINE | ID: mdl-31748954
18.
Testicular Cancer, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology.
J Natl Compr Canc Netw
; 17(12): 1529-1554, 2019 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-31805523
19.
Highlights in metastatic urothelial cancer from the European Society for Medical Oncology Congress 2023: commentary.
Clin Adv Hematol Oncol
; 21 Suppl 6(12): 15-17, 2023 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-38307621
20.
JAVELIN: avelumab another spear to fight urothelial carcinoma.
Lancet Oncol
; 19(1): 5-7, 2018 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-29217289